Philip H. Coelho - 21 Nov 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Philip H. Coelho
Issuer symbol
CPRX
Transactions as of
21 Nov 2022
Net transactions value
-$1,586,750
Form type
4
Filing time
23 Nov 2022, 16:00:19 UTC
Previous filing
15 Sep 2022
Next filing
08 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Sale $1,066,170 -70,000 -28% $15.23 179,553 21 Nov 2022 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Sale $346,097 -20,001 -11% $17.30 159,552 22 Nov 2022 Direct F1, F3
transaction CPRX Common stock, par value $0.001 per share Sale $174,483 -9,999 -6.3% $17.45 149,553 23 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Mr. Coelho remains a director of the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.01 to $15.59 per share.
F3 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $17.28 to $17.335 per share.